OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany - Takeaways - DentalSpire

OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany

  • By

  • C. N. Martin

  • N. De Lazzari

  • J. Kersten

  • K. Claassen

  • C. Jansen

  • K. Kaminski

  • F. Baumann

  • M. Götte

  • S. Palm

  • A. Stang

  • V. Grünwald

  • U. Dirksen

  • M. A. Teufel

  • E.-M. Skoda

  • October 24, 2025

  • 0 min

Share

  • 1

    The OPTILATER project evaluates the long-term survival and care conditions of cancer survivors in Germany, focusing on late effects and follow-up care.

  • 2

    In 2017, Germany had 4.65 million cancer survivors, with two-thirds being long-term survivors who have been cancer-free for five years.

  • 3

    The study addresses gaps in knowledge regarding therapy-associated late effects and the care needs of cancer survivors, particularly those with migration backgrounds.

  • 4

    Work Package 3 of the OPTILATER project collects data on socioeconomic status, health-related quality of life, and unmet needs among long-term cancer survivors.

  • 5

    The study employs a cross-sectional survey design to assess survivors' experiences and barriers to healthcare access, aiming to improve survivorship care.

Original Source(s)

OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany

  • by C. N. Martin, N. De Lazzari, J. Kersten, K. Claassen, C. Jansen, K. Kaminski, F. Baumann, M. Götte, S. Palm, A. Stang, V. Grünwald, U. Dirksen, M. A. Teufel, E.-M. Skoda

  • October 24, 2025

Related Content

Analyzing pediatric forearm X-rays for fracture analysis using machine learning

Paediatric traumatic brain injury: unique population and unique challenges

Spatial transcriptomics uncovers TAC-OGEs heterogeneity and FN1/MMP9 signature in ameloblastoma